Cargando…
ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets
Spinal muscular atrophy (SMA) is the most common genetic disease causing infant death, due to an extended loss of motoneurons. This neuromuscular disorder results from deletions and/or mutations within the Survival Motor Neuron 1 (SMN1) gene, leading to a pathological decreased expression of functio...
Autores principales: | Coque, Emmanuelle, Raoul, Cédric, Bowerman, Mélissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148024/ https://www.ncbi.nlm.nih.gov/pubmed/25221469 http://dx.doi.org/10.3389/fnins.2014.00271 |
Ejemplares similares
-
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
por: Bowerman, Melissa, et al.
Publicado: (2017) -
The Relationship between Body Composition, Fatty Acid Metabolism and Diet in Spinal Muscular Atrophy
por: Watson, Katherine S., et al.
Publicado: (2021) -
Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment
por: Menduti, Giovanna, et al.
Publicado: (2020) -
Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
por: Bowerman, Melissa, et al.
Publicado: (2012) -
Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)